Fennec Pharmaceuticals (TSX:FRX) Price-to-Operating-Cash-Flow : (As of Apr. 28, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Fennec Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-04-28), Fennec Pharmaceuticals's share price is C$12.58. Fennec Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.87. Hence, Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSX:FRX's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.65
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Fennec Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Dec. 2023 was C$-0.24. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.87.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -0.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -10.10% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -19.50% per year.

During the past 13 years, Fennec Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 61.40% per year. The lowest was -88.10% per year. And the median was 9.75% per year.

Fennec Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fennec Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Fennec Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Fennec Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Fennec Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	12.58	/	-0.869
	=

Fennec Pharmaceuticals's Share Price of today is C$12.58.
Fennec Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.87.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Fennec Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Fennec Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Fennec Pharmaceuticals (TSX:FRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (TSX:FRX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

FENC:USA RV41:Germany

Address

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709

Website

https://www.fennecpharma.com

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.